Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -3.06% | 72.47 | 1.0% | $1887.03m | |
| AMGN | Amgen, Inc. | -2.41% | 197.84 | 1.3% | $881.55m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.89% | 497.54 | 2.6% | $849.60m | |
| BIIB | Biogen, Inc. | -7.23% | 293.51 | 1.5% | $704.33m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -5.29% | 225.36 | 1.9% | $557.17m | |
| MRNA | Moderna, Inc. | -0.74% | 29.73 | 0.0% | $531.71m | |
| ILMN | Illumina, Inc. | -6.16% | 256.30 | 3.5% | $443.16m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.15% | 89.92 | 2.0% | $286.46m | |
| A | Agilent Technologies, Inc. | -3.90% | 68.83 | 1.6% | $219.69m | |
| EXAS | EXACT Sciences Corp. | -3.81% | 55.79 | 21.0% | $186.98m | |
| INCY | Incyte Corp. | 1.24% | 74.14 | 2.5% | $178.78m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.15% | 83.53 | 4.3% | $164.46m | |
| SGEN | Seattle Genetics, Inc. | -3.57% | 111.27 | 6.1% | $163.46m | |
| NVAX | Novavax, Inc. | 3.17% | 14.01 | 114.7% | $128.78m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -3.77% | 104.75 | 8.7% | $98.57m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.